graft-versus-host disease

Lycera Graduates from Incubator to North Campus Research ComplexLycera, a biopharmaceutical company and University of Michigan spinoff, plans to partner and collaborate with U-M faculty and students with a move to UM’s North Campus Research Complex.
Prototype Drug Halts Disease That Limits Bone Marrow TransplantsA prototype drug already shown to hold promise for treating autoimmune disorders like lupus, arthritis and psoriasis halts established graft-versus-host disease in mouse models of bone marrow transplantation, research at the University of Michigan and the University of Florida shows
UM Research Shows Promise In Bone Marrow Transplantation
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen